$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
12:16pm, Wednesday, 03'rd Apr 2024
Amgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health, nephrology and neur
Biotech Sector Nears Breakout: Will it Outperform in Q2?
06:11am, Wednesday, 03'rd Apr 2024
The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:06pm, Monday, 01'st Apr 2024
Amgen (AMGN) closed the most recent trading day at $283.04, moving -0.45% from the previous trading session.
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
01:15pm, Monday, 01'st Apr 2024
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
11:15am, Sunday, 31'st Mar 2024
Eli Lilly's stock has seen significant growth due to the success of its obesity drug, "Zepbound," but its high valuation and upcoming competition make it less attractive. Amgen, with its obesity candi
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 29'th Mar 2024
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Thursday, 28'th Mar 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
3 Biotech Stocks to Buy on the Dip: March 2024
01:07pm, Wednesday, 27'th Mar 2024
One of the best dip-buying opportunities in biotech stocks to buy was in Viking Therapeutics (NASDAQ: VKTX ). After hitting a high of $99.41, VKTX dipped back to about $60.30.
7 Dow Stocks to Buy on the Dip: March 2024
06:00am, Wednesday, 27'th Mar 2024
The Dow Jones Industrial Average recently made new all-time highs, reaching a peak of 39,889. This has set off great excitement, with 40,000 seeming imminent and the possibility of Dow 50,000 starting
Wall Street Awaits Consumer Confidence Data
11:26am, Tuesday, 26'th Mar 2024
U.S. stock markets saw a pullback on Monday to start a holiday-shortened week. However, Wall Street is likely to record the fifth consecutive winning month despite volatility.
Wall Street Set to Post Fifth Winning Month Amid Volatility
03:36am, Tuesday, 26'th Mar 2024
Wall Street is likely to record the fifth consecutive winning month despite volatility.
Amgen (AMGN) Ascends While Market Falls: Some Facts to Note
06:55pm, Monday, 25'th Mar 2024
In the most recent trading session, Amgen (AMGN) closed at $280.82, indicating a +1.68% shift from the previous trading day.
Buffett's Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
01:05pm, Monday, 25'th Mar 2024
Warren Buffett stocks can teach you a thing or two about investing. Warren Buffett's annual shareholders letter to Berkshire Hathaway (NYSE: BRK-A )(NYSE: BRK-B ) investors outlines what he's done the
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
08:00am, Sunday, 24'th Mar 2024
Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
05:29pm, Thursday, 21'st Mar 2024
When it comes to risk vs. reward in the stock market, the biotech sector has one of the highest potential payoffs.
Sign In
Buy AMGN